Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria.
about
Depression in patients with mastocytosis: prevalence, features and effects of masitinib therapyPharmacological treatment options for mast cell activation diseaseCytokine Regulation of Microenvironmental Cells in Myeloproliferative NeoplasmsKIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on MastocytosisMast Cell Clonal Disorders: Classification, Diagnosis and ManagementTarget interaction profiling of midostaurin and its metabolites in neoplastic mast cells predicts distinct effects on activation and growthHypotension, Syncope, and Fever in Systemic Mastocytosis without Skin Infiltration and Rapid Response to Corticosteroid and Cyclosporin: A Case Report.Validation of the REMA score for predicting mast cell clonality and systemic mastocytosis in patients with systemic mast cell activation symptoms.High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience.Mastocytosis.The presence of mast cell clonality in patients with unexplained anaphylaxis.Hymenoptera Allergy and Mast Cell Activation Syndromes.Systemic mastocytosis with KIT V560G mutation presenting as recurrent episodes of vascular collapse: response to disodium cromoglycate and disease outcomeSystemic mastocytosis in the elderly.Nilotinib in patients with systemic mastocytosis: analysis of the phase 2, open-label, single-arm nilotinib registration studyClinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patients.Eosinophilic myeloproliferative disordersMast cell activation syndrome: Proposed diagnostic criteria.Mast cell activation syndromes: definition and classification.Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposalSingle nucleotide polymorphism array lesions, TET2, DNMT3A, ASXL1 and CBL mutations are present in systemic mastocytosis.The expression of melanoma inhibitory activity on mast cells in child patients with cutaneous mastocytosis.Telangiectasia macularis eruptiva perstans: more than skin deep.Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future.Asymptomatic solitary cutaneous mastocytoma: a rare presentation.Recent advances in the understanding of mastocytosis: the role of KIT mutations.Prostaglandin D2-supplemented "functional eicosanoid testing and typing" assay with peripheral blood leukocytes as a new tool in the diagnosis of systemic mast cell activation disease: an explorative diagnostic study.Familial occurrence of systemic mast cell activation disease.Diagnosis and treatment of mast cell disorders: practical recommendations.Long-lasting complete response to imatinib in a patient with systemic mastocytosis exhibiting wild type KIT.Determination of plasma heparin level improves identification of systemic mast cell activation diseasePTEN deficiency in mast cells causes a mastocytosis-like proliferative disease that heightens allergic responses and vascular permeabilityDefinitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposalCutaneous Mastocytosis with Persistent Blistering: Successful Treatment with Methylprednisolone and 3-Year Follow-Up Management.Improved detection of the KIT D816V mutation in patients with systemic mastocytosis using a quantitative and highly sensitive real-time qPCR assay.Neuro-inflammation, blood-brain barrier, seizures and autism.Pregnancy and Delivery in Patients with Mastocytosis Treated at the Polish Center of the European Competence Network on Mastocytosis (ECNM).Systemic mastocytosis presenting with gastrointestinal, bone and skin involvementIncreased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosisMastocytosis: a mutated KIT receptor induced myeloproliferative disorder
P2860
Q21560915-DE4ECB7C-46DF-43C5-A033-367F3075855FQ26748784-8E3482CC-1CA3-415C-865F-5F9287592080Q26778929-39C18A34-CDE2-419C-ADE6-0DF5DC42A610Q26830207-9D5C05F2-939D-4252-8AC4-1F0232D33A95Q28070386-35DA080D-E6A1-42F5-8876-882C3299EA94Q28828739-D9366E24-0885-4395-87F6-82D6DFEDA2DDQ33159586-EAF240AD-94C9-41FC-99CE-EB5BE18A53D6Q33160609-A737C3B2-16D5-468B-AB63-7F3B880455A4Q33163450-67AE7A81-E2FF-466A-A4B4-17EB5A3C6E6EQ33163541-122FED58-86CE-4B48-9F67-6767384BBEB7Q33164531-5A3A208F-89EE-4DE1-93BC-1756B536DA08Q33166619-9BEEB3B7-EDA1-4148-BDA9-46E85E1120E2Q33168552-BECDE408-B38E-4A4B-ABE0-5A683166F5EEQ33406056-38143A9B-9CFA-436F-AAD6-0C598609CA17Q33423072-5B9B25EE-0A74-4532-9830-E26ED0898704Q33431360-2E8791F9-4750-4FE3-9ED3-E71D670C4AA8Q33881283-ED8288F2-2CAD-4854-940B-6BB2E7588F2BQ34024510-062D20B1-60E0-4EA5-9C83-CC822CD1DF2AQ34035582-1F95FD83-1913-4880-A0E2-436516243F3BQ34137971-11222257-B208-4E0F-85E9-A3A485ECE739Q34384728-50CF5F02-0C36-47E1-BB78-DFC0C37F2583Q34403961-1CD901D3-780A-46AA-BBB7-923812276135Q34413811-8C222ADA-EA24-4C6D-A927-52B3A6FFC129Q34552564-760367F3-5A43-4C01-BD84-94D8E6714C4AQ34591682-210F46BF-8092-4201-8BBB-ACBE6F47D50AQ34635424-4642BF5B-5464-4346-82D9-C968C2CCA046Q34812525-22AE752A-192B-4F14-9AF2-CEFB344AF344Q35010297-8A272D4C-A947-4E0C-B3E7-C20759A54DEBQ35021196-4874F9F7-BADC-43C2-A0C7-4395A563B16CQ35153623-2C633460-5A11-4C2D-84B7-2866660DADE8Q35536695-10ED2F33-C34C-495A-A7D6-C3CD694CA66FQ35553313-17B505D3-3711-49E8-9DF1-D7287FF9B63FQ35574171-FF98F4B8-8F52-408C-ADC9-AC26EB099E76Q35752513-A21A797F-AFCB-4CFA-AA4A-6C6C57D39E5EQ35757696-BB9364ED-E2EC-4849-A58D-D0063D679E9FQ35800334-2F9D9C23-87C5-4791-9246-2689FA934F4CQ35900583-0C490D0A-8C5B-43D6-8653-BC5B4A0EBEA9Q35929253-5E1044CE-CDB2-4CC5-9B8B-EE9B30A434C1Q35951578-9D307A87-B0B0-435C-8EFD-268C2BBF8592Q36210845-6414EBFF-C400-46C1-8623-946888EF8EC6
P2860
Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Standards and standardization ...... dations and response criteria.
@en
type
label
Standards and standardization ...... dations and response criteria.
@en
prefLabel
Standards and standardization ...... dations and response criteria.
@en
P2093
P1476
Standards and standardization ...... dations and response criteria.
@en
P2093
Castells M
Escribano L
Födinger M
Hartmann K
Hauswirth AW
Hellmann A
P304
P356
10.1111/J.1365-2362.2007.01807.X
P577
2007-06-01T00:00:00Z